These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 18332079
1. Hepatic uptake and excretion of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel if channel inhibitor, in rats and humans. Umehara K, Iwai M, Adachi Y, Iwatsubo T, Usui T, Kamimura H. Drug Metab Dispos; 2008 Jun; 36(6):1030-8. PubMed ID: 18332079 [Abstract] [Full Text] [Related]
2. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites. Umehara K, Shirai N, Iwatsubo T, Noguchi K, Usui T, Kamimura H. Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489 [Abstract] [Full Text] [Related]
3. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans. Yamashiro W, Maeda K, Hirouchi M, Adachi Y, Hu Z, Sugiyama Y. Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871 [Abstract] [Full Text] [Related]
4. Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans. Ishiguro N, Maeda K, Kishimoto W, Saito A, Harada A, Ebner T, Roth W, Igarashi T, Sugiyama Y. Drug Metab Dispos; 2006 Jul; 34(7):1109-15. PubMed ID: 16611857 [Abstract] [Full Text] [Related]
10. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3. Gozalpour E, Greupink R, Wortelboer HM, Bilos A, Schreurs M, Russel FG, Koenderink JB. Mol Pharm; 2014 Jun 02; 11(6):1844-55. PubMed ID: 24754247 [Abstract] [Full Text] [Related]
11. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide. Jeong HU, Kwon M, Lee Y, Yoo JS, Shin DH, Song IS, Lee HS. Drug Des Devel Ther; 2015 Jun 02; 9():643-53. PubMed ID: 25653502 [Abstract] [Full Text] [Related]
12. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3. Noé J, Portmann R, Brun ME, Funk C. Drug Metab Dispos; 2007 Aug 02; 35(8):1308-14. PubMed ID: 17470528 [Abstract] [Full Text] [Related]
13. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport. Kindla J, Müller F, Mieth M, Fromm MF, König J. Drug Metab Dispos; 2011 Jun 02; 39(6):1047-53. PubMed ID: 21389119 [Abstract] [Full Text] [Related]
14. Inhibition of hepatic uptake transporters by flavonoids. Mandery K, Balk B, Bujok K, Schmidt I, Fromm MF, Glaeser H. Eur J Pharm Sci; 2012 May 12; 46(1-2):79-85. PubMed ID: 22394605 [Abstract] [Full Text] [Related]
17. The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide. Miyagawa M, Maeda K, Aoyama A, Sugiyama Y. J Pharmacol Exp Ther; 2009 May 12; 329(2):551-7. PubMed ID: 19244099 [Abstract] [Full Text] [Related]
20. Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes. Badolo L, Trancart MM, Gustavsson L, Chesné C. Chem Biol Interact; 2011 Apr 25; 190(2-3):165-70. PubMed ID: 21356203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]